Clinical Trial Update: A Phase 2 Study of ABBV-3067 Alone and in Combination With ABBV-2222 [Phase 2]

View source ↗

Summary

Phase 2 study of ABBV-3067 alone and with ABBV-2222 in cystic fibrosis completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• ABBV-2222 (ABBV-2222)
• ABBV-3067 (ABBV-3067)

Snippet

Sponsor: AbbVie | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2023-06-28